StonvexLoading…
StonvexStonvexStonvexCore line items from TGNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.25K | $444.53K | $731.68K | $19.50K |
Operating Income | $-454.99K | $-884.68K | $-353.96K | $-551.60K |
Net Income | $-600.05K | $-947.24K | $-402.17K | $-592.08K |
EPS (Diluted) | $0.00 | $0.00 | $0.00 | Not available |
Total Assets | $206.47K | $222.93K | $486.80K | $149.05K |
Total Liabilities | $2.37M | $1.96M | $1.40M | $910.14K |
Cash & Equivalents | $4.69K | $22.13K | $167.74K | $14.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | $-29.48K | $-199.52K |
Shares Outstanding | 213.60M | 172.91M | 172.91M | 94.76M |